Tegretol

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:approves gptkb:1974
gptkb:FDA
gptkbp:atccode N03 AF01
gptkbp:available_on generic
gptkbp:brand gptkb:Carbatrol
gptkb:Equetro
Tegretol XR
gptkbp:casnumber 298-46-4
gptkbp:category gptkb:D
gptkb:L3
gptkbp:chemical_formula C15 H12 N2 O
gptkbp:clinical_trial NCT00000123
NCT00000456
NCT00000789
NCT00001012
NCT00001345
gptkbp:contraindication hypersensitivity to carbamazepine
bone marrow depression
gptkbp:discovered_by gptkb:John_C._Mc_Donald
gptkbp:form gptkb:tablet
suspension
extended-release tablet
https://www.w3.org/2000/01/rdf-schema#label Tegretol
gptkbp:ingredients gptkb:carbamazepine
gptkbp:interacts_with gptkb:warfarin
oral contraceptives
MAO inhibitors
other anticonvulsants
gptkbp:legal_status prescription only
gptkbp:lifespan 25 to 65 hours
gptkbp:marketed_as gptkb:Mylan
gptkb:Teva_Pharmaceuticals
gptkb:Sandoz
gptkb:Novartis
gptkbp:metabolism liver
gptkbp:packaging gptkb:bottle
blister pack
gptkbp:route_of_administration oral
gptkbp:side_effect dizziness
nausea
drowsiness
dry mouth
blurred vision
gptkbp:storage room temperature
gptkbp:used_for gptkb:epilepsy
bipolar disorder
trigeminal neuralgia
gptkbp:bfsParent gptkb:carbamazepine
gptkbp:bfsLayer 5